PROTAC

Muzi Ouyang1,2, Ying Feng1, Hui Chen1,2

  • 1State Key Laboratory of Chemical Oncogenomics, Institute of Biomedical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.

PubMed
概括

通过选择性降解疾病蛋白质,光学控制的蛋白质分解向仿真体 (PROTACs) 提供了一种新的抗癌疗法. 提高PROTAC的特异性提高了安全性,并扩大了药物发现中的治疗应用.